The future of biotechnology and life sciences sector: Are we at a tipping point?

The biopharmaceutical industry is often criticized for putting profit above patient welfare. But scientific advances are now leading to a surge in breakthrough medicines that should remind people of the pivotal role the industry has always played in improving the length and quality of patient lives. The promise of this surge in scientific innovation, however, won’t be fully realized unless it can be matched with innovation in how drug companies bring products to market—with a focus on increasing efficiency and speed while reducing costs.